
Hypolipidemic activity of the polysaccharide L-rhamnopyranosyl-6-O-methyl-galacturonan in combined administration with HMG-CoA reductase and cholesterol absorption inhibitors
Author(s) -
E. E. Buyko,
В. В. Иванов,
О. А. Кайдаш,
O. Yu. Rybalkina,
Е. А. Киселева,
С. В. Кривощеков,
T. L. Kiseleva,
А. M. Guriev,
М. В. Белоусов
Publication year - 2022
Publication title -
razrabotka i registraciâ lekarstvennyh sredstv
Language(s) - English
Resource type - Journals
eISSN - 2658-5049
pISSN - 2305-2066
DOI - 10.33380/2305-2066-2022-11-3-57-63
Subject(s) - rosuvastatin , enterohepatic circulation , ezetimibe , chemistry , cholesterol , reductase , cholestyramine , hyperlipidemia , bile acid , polysaccharide , blood lipids , dyslipidemia , oral administration , statin , hmg coa reductase , pharmacology , biochemistry , medicine , endocrinology , enzyme , obesity , diabetes mellitus